| Pharmaceutical active ingredients: |
| Oxymetazoline Hydrochloride |
| Available forms, composition and doses of Nasal Decongestant Maximum Strength: |
| N / A |
| Nasal Decongestant Maximum Strength medical category: |
| Human:Nasal decongestants and other nasal preparationsOphthalmic decongestants, anesthetics, anti-inflammatoriesVasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AA05 - OxymetazolineR01AB07 - OxymetazolineS01GA04 - Oxymetazoline |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Taro Pharmaceutical Industries |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Midazol | Midazolam | Taro Pharmaceutical Industries |
| Mometasone | Mometasone Furoate | Taro Pharmaceutical Industries |
| Mycurium | Atracurium Besylate | Taro Pharmaceutical Industries |
| Napril | Enalapril Maleate | Taro Pharmaceutical Industries |
| Naprizide | Enalapril Maleate; Hydrochlorothiazide | Taro Pharmaceutical Industries |
| Neo-Dentocain | Benzocaine; Menthol; Phenylephrine Hydrochloride | Taro Pharmaceutical Industries |
| Nitrofurazone | Nitrofurazone | Taro Pharmaceutical Industries |
| Nitroglycerin alcohol free | Nitroglycerin | Taro Pharmaceutical Industries |
| Noralone | Nandrolone Phenylpropionate | Taro Pharmaceutical Industries |
| Nortriptyline | Nortriptyline Hydrochloride | Taro Pharmaceutical Industries |